Big Buttons

• PCAC to discuss 503A bulks list substances

  FDA’s Pharmacy Compounding Advisory Committee has announced that it will hold two meetings (!) between now and year-end to consider recommending several bulk drug substances to the 503A Bulks List.  read more →

• Next APC regional meeting: Seattle

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Seattle area October 3. read more →

• Don’t skip EduCon’s final (fantastic) session(s)

  The final session of this year’s EduCon is coming up in just a few weeks, and it’s a special double helping of legal goodness. read more →

• Welcome, new PFMs!

  We’ve added 31 Pharmacy-Facility Members since February! read more →

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

More News

APC has signed onto a letter of support for the sponsors of H.R. 3554 and S. 1909, the Pharmacy DIR Reform to Reduce Senior Drug Costs Act. But we need more than just thanking the sponsors — we need more sponsors!

We know you’re busy, so our friends at NCPA are making it easy. One click is all you need. Go here to contact your senators and representative and urge them to support bipartisan pharmacy DIR reform efforts by cosponsoring S. 1909/H.R. 3554, the Pharmacy DIR Reform to Reduce Senior Drug Costs Act.

Pharmacy DIR fees grew 91,500% between 2010 and 2019, more than doubling between 2017 and 2019. Ridiculous? You bet it is. DIR fees are out of control and are unsustainable.

We need your help! Voice your support for this important legislation for community pharmacy.